- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT00112528
Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
Phase II Trial of Bevacizumab, Gemcitabine, Oxaliplatin in Patients With Metastatic Pancreatic Adenocarcinoma
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of pancreatic cancer by blocking blood flow to the tumor. Drugs used in chemotherapy, such as gemcitabine and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving bevacizumab together with gemcitabine and oxaliplatin may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving bevacizumab together with gemcitabine and oxaliplatin works in treating patients with metastatic pancreatic cancer.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
OBJECTIVES:
Primary
- Determine the 6-month survival of patients with metastatic adenocarcinoma of the pancreas treated with bevacizumab, gemcitabine, and oxaliplatin.
Secondary
- Determine the objective response rate in patients with measurable disease treated with this regimen.
- Determine median survival, progression-free survival, time to treatment failure, and overall survival of patients treated with this regimen.
- Determine the toxicity of this regimen in these patients.
OUTLINE: This is a multicenter study.
Patients receive gemcitabine IV over 100 minutes and bevacizumab IV over 30-90 minutes on days 1 and 15. Patients also receive oxaliplatin IV over 120 minutes on days 2 and 16. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients achieving a complete response (CR) receive 2 courses of therapy beyond CR.
After completion of study treatment, patients are followed every 3-6 months for up to 5 years.
Tipo de estudio
Inscripción (Actual)
Fase
- Fase 2
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Alabama
-
Mobile, Alabama, Estados Unidos, 36652-2144
- Mobile Infirmary Medical Center
-
-
Arizona
-
Scottsdale, Arizona, Estados Unidos, 85259
- Mayo Clinic Scottsdale
-
-
Colorado
-
Aurora, Colorado, Estados Unidos, 80012
- Aurora Presbyterian Hospital
-
Boulder, Colorado, Estados Unidos, 80301-9019
- Boulder Community Hospital
-
Colorado Springs, Colorado, Estados Unidos, 80933
- Penrose Cancer Center at Penrose Hospital
-
Denver, Colorado, Estados Unidos, 80210
- Porter Adventist Hospital
-
Denver, Colorado, Estados Unidos, 80220
- Rose Medical Center
-
Denver, Colorado, Estados Unidos, 80218
- Presbyterian - St. Luke's Medical Center
-
Denver, Colorado, Estados Unidos, 80218
- St. Joseph Hospital
-
Denver, Colorado, Estados Unidos, 80224-2522
- CCOP - Colorado Cancer Research Program, Incorporated
-
Englewood, Colorado, Estados Unidos, 80110
- Swedish Medical Center
-
Fort Collins, Colorado, Estados Unidos, 80524
- Front Range Cancer Specialists
-
Lone Tree, Colorado, Estados Unidos, 80124
- Sky Ridge Medical Center
-
Longmont, Colorado, Estados Unidos, 80502
- Hope Cancer Care Center at Longmont United Hospital
-
Pueblo, Colorado, Estados Unidos, 81004
- St. Mary-Corwin Regional Medical Center
-
Thorton, Colorado, Estados Unidos, 80229
- North Suburban Medical Center
-
-
Florida
-
Jacksonville, Florida, Estados Unidos, 32224
- Mayo Clinic - Jacksonville
-
-
Hawaii
-
Aiea, Hawaii, Estados Unidos, 96701
- Kapiolani Medical Center at Pali Momi
-
Honolula, Hawaii, Estados Unidos, 96813
- Cancer Research Center of Hawaii
-
Honolulu, Hawaii, Estados Unidos, 96826
- Kapiolani Medical Center for Women and Children
-
Honolulu, Hawaii, Estados Unidos, 96813
- OnCare Hawaii, Incorporated - Lusitana
-
Honolulu, Hawaii, Estados Unidos, 96813
- Queen's Cancer Institute at Queen's Medical Center
-
Honolulu, Hawaii, Estados Unidos, 96813
- Straub Clinic and Hospital, Incorporated
-
Honolulu, Hawaii, Estados Unidos, 96817
- OnCare Hawaii, Incorporated - Kuakini
-
Honolulu, Hawaii, Estados Unidos, 96817
- St. Francis Medical Center
-
-
Illinois
-
Aurora, Illinois, Estados Unidos, 60507
- Rush-Copley Cancer Care Center
-
Bloomington, Illinois, Estados Unidos, 61701
- St. Joseph Medical Center
-
Canton, Illinois, Estados Unidos, 61520
- Graham Hospital
-
Carthage, Illinois, Estados Unidos, 62321
- Memorial Hospital
-
Effingham, Illinois, Estados Unidos, 62401
- St. Anthony's Memorial Hospital
-
Eureka, Illinois, Estados Unidos, 61530
- Eureka Community Hospital
-
Galesburg, Illinois, Estados Unidos, 61401
- Galesburg Cottage Hospital
-
Galesburg, Illinois, Estados Unidos, 61401
- Galesburg Clinic
-
Havana, Illinois, Estados Unidos, 62644
- Mason District Hospital
-
Hopedale, Illinois, Estados Unidos, 61747
- Hopedale Medical Complex
-
Joliet, Illinois, Estados Unidos, 60435
- Joliet Oncology-Hematology Associates, Limited - West
-
Kewanee, Illinois, Estados Unidos, 61443
- Kewanee Hospital
-
Macomb, Illinois, Estados Unidos, 61455
- Mcdonough District Hospital
-
Moline, Illinois, Estados Unidos, 61265
-
Moline, Illinois, Estados Unidos, 61265
- Trinity Medical Center - East
-
Normal, Illinois, Estados Unidos, 61761
- Bromenn Regional Medical Center
-
Normal, Illinois, Estados Unidos, 61761
- Community Cancer Center
-
Ottawa, Illinois, Estados Unidos, 61350
- Community Hospital of Ottawa
-
Ottawa, Illinois, Estados Unidos, 61350
- Oncology Hematology Associates of Central Illinois, PC - Ottawa
-
Pekin, Illinois, Estados Unidos, 61554
- Cancer Treatment Center at Pekin Hospital
-
Peoria, Illinois, Estados Unidos, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Estados Unidos, 61614
- Proctor Hospital
-
Peoria, Illinois, Estados Unidos, 61637
- OSF St. Francis Medical Center
-
Peoria, Illinois, Estados Unidos, 61615
- CCOP - Illinois Oncology Research Association
-
Peoria, Illinois, Estados Unidos, 61615
- Oncology Hematology Associates of Central Illinois, PC - Peoria
-
Peru, Illinois, Estados Unidos, 61354
- Illinois Valley Community Hospital
-
Princeton, Illinois, Estados Unidos, 61356
- Perry Memorial Hospital
-
Spring Valley, Illinois, Estados Unidos, 61362
- St. Margaret's Hospital
-
Urbana, Illinois, Estados Unidos, 61801
- Carle Cancer Center at Carle Foundation Hospital
-
Urbana, Illinois, Estados Unidos, 61801
- CCOP - Carle Cancer Center
-
-
Indiana
-
Michigan City, Indiana, Estados Unidos, 46360
- Saint Anthony Memorial Health Centers
-
-
Iowa
-
Ames, Iowa, Estados Unidos, 50010
- McFarland Clinic, P. C.
-
Bettendorf, Iowa, Estados Unidos, 52722
-
Cedar Rapids, Iowa, Estados Unidos, 52402
- St. Luke's Hospital
-
Cedar Rapids, Iowa, Estados Unidos, 52403
- Cedar Rapids Oncology Associates
-
Cedar Rapids, Iowa, Estados Unidos, 52403
- Mercy Regional Cancer Center at Mercy Medical Center
-
Des Moines, Iowa, Estados Unidos, 50309
- CCOP - Iowa Oncology Research Association
-
Des Moines, Iowa, Estados Unidos, 50309
- John Stoddard Cancer Center at Iowa Methodist Medical Center
-
Des Moines, Iowa, Estados Unidos, 50309
- Medical Oncology and Hematology Associates at John Stoddard Cancer Center
-
Des Moines, Iowa, Estados Unidos, 50314
- Medical Oncology and Hematology Associates at Mercy Cancer Center
-
Des Moines, Iowa, Estados Unidos, 50314
- Mercy Cancer Center at Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Estados Unidos, 50307
- Mercy Capitol Hospital
-
Des Moines, Iowa, Estados Unidos, 50316-2301
- John Stoddard Cancer Center at Iowa Lutheran Hospital
-
Ottumwa, Iowa, Estados Unidos, 52501
- Ottumwa Regional Health Center Cancer Center
-
Sioux City, Iowa, Estados Unidos, 51101
- Siouxland Regional Cancer Center
-
Sioux City, Iowa, Estados Unidos, 51101
- Siouxland Hematology-Oncology Associates, LLP
-
Sioux City, Iowa, Estados Unidos, 51104
- St. Luke's Regional Medical Center
-
Sioux City, Iowa, Estados Unidos, 51104
- Mercy Medical Center - Sioux City
-
West Des Moines, Iowa, Estados Unidos, 50266
- Medical Oncology and Hematology Associates - West Des Moines
-
-
Kansas
-
Chanute, Kansas, Estados Unidos, 66720
- Cancer Center of Kansas, PA - Chanute
-
Dodge City, Kansas, Estados Unidos, 67801
- Cancer Center of Kansas, PA - Dodge City
-
El Dorado, Kansas, Estados Unidos, 67042
- Cancer Center of Kansas, PA - El Dorado
-
Kingman, Kansas, Estados Unidos, 67068
- Cancer Center of Kansas, PA - Kingman
-
Liberal, Kansas, Estados Unidos, 67901
- Southwest Medical Center
-
Newton, Kansas, Estados Unidos, 67114
- Cancer Center of Kansas, PA - Newton
-
Parsons, Kansas, Estados Unidos, 67357
- Cancer Center of Kansas, PA - Parsons
-
Pratt, Kansas, Estados Unidos, 67124
- Cancer Center of Kansas, PA - Pratt
-
Salina, Kansas, Estados Unidos, 67042
- Cancer Center of Kansas, PA - Salina
-
Wellington, Kansas, Estados Unidos, 67152
- Cancer Center of Kansas, PA - Wellington
-
Wichita, Kansas, Estados Unidos, 67203
- Associates in Womens Health, PA - North Review
-
Wichita, Kansas, Estados Unidos, 67208
- Cancer Center of Kansas, PA - Medical Arts Tower
-
Wichita, Kansas, Estados Unidos, 67214
- Cancer Center of Kansas, PA - Wichita
-
Wichita, Kansas, Estados Unidos, 67214
- CCOP - Wichita
-
Wichita, Kansas, Estados Unidos, 67214
- Via Christi Cancer Center at Via Christi Regional Medical Center
-
Winfield, Kansas, Estados Unidos, 67156
- Cancer Center of Kansas, PA - Winfield
-
-
Michigan
-
Adrian, Michigan, Estados Unidos, 49221
- Hickman Cancer Center at Bixby Medical Center
-
Ann Arbor, Michigan, Estados Unidos, 48106
- CCOP - Michigan Cancer Research Consortium
-
Ann Arbor, Michigan, Estados Unidos, 48106-0995
- St. Joseph Mercy Cancer Center at St. Joseph Mercy Hospital
-
Dearborn, Michigan, Estados Unidos, 48123-2500
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
-
Escanaba, Michigan, Estados Unidos, 49431
- Green Bay Oncology, Limited - Escanaba
-
Flint, Michigan, Estados Unidos, 48503
- Hurley Medical Center
-
Flint, Michigan, Estados Unidos, 48503
- Genesys Hurley Cancer Institute
-
Grosse Pointe Woods, Michigan, Estados Unidos, 48236
- Van Elslander Cancer Center at St. John Hospital and Medical Center
-
Iron Mountain, Michigan, Estados Unidos, 49801
- Green Bay Oncology, Limited - Iron Mountain
-
Jackson, Michigan, Estados Unidos, 49201
- Foote Hospital
-
Lambertville, Michigan, Estados Unidos, 48144
- Haematology-Oncology Associates of Ohio and Michigan, P.C.
-
Lansing, Michigan, Estados Unidos, 48909
- Sparrow Regional Cancer Center
-
Monroe, Michigan, Estados Unidos, 48162
- Community Cancer Center of Monroe
-
Monroe, Michigan, Estados Unidos, 48162
- Mercy Memorial Hospital System
-
Saginaw, Michigan, Estados Unidos, 48601
- Seton Cancer Institute - Saginaw
-
Warren, Michigan, Estados Unidos, 48093
- St. John Macomb Hospital
-
-
Minnesota
-
Alexandria, Minnesota, Estados Unidos, 56308
-
Bemidji, Minnesota, Estados Unidos, 56601
- MeritCare Clinic - Bemidji
-
Brainerd, Minnesota, Estados Unidos, 56401
- Brainerd Medical Center
-
Brainerd, Minnesota, Estados Unidos, 56401
- St. Joseph's Medical Center
-
Burnsville, Minnesota, Estados Unidos, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, Estados Unidos, 55433
- Mercy and Unity Cancer Center at Mercy Hospital
-
Edina, Minnesota, Estados Unidos, 55435
- Fairview Southdale Hospital
-
Fergus Falls, Minnesota, Estados Unidos, 56537
-
Fridley, Minnesota, Estados Unidos, 55432
- Mercy and Unity Cancer Center at Unity Hospital
-
Hutchinson, Minnesota, Estados Unidos, 55350
- Hutchinson Area Health Care
-
Lichfield, Minnesota, Estados Unidos, 55355
- Meeker County Memorial Hospital
-
Maplewood, Minnesota, Estados Unidos, 55109
- HealthEast Cancer Care at St. John's Hospital
-
Minneapolis, Minnesota, Estados Unidos, 55415
- Hennepin County Medical Center - Minneapolis
-
Minneapolis, Minnesota, Estados Unidos, 55407
- Virginia Piper Cancer Institute at Abbott-Northwestern Hospital
-
Montevideo, Minnesota, Estados Unidos, 56265
- Chippewa County - Montevideo Hospital
-
Robbinsdale, Minnesota, Estados Unidos, 55422-2900
- Hubert H. Humphrey Cancer Center at North Memorial Medical Center
-
Rochester, Minnesota, Estados Unidos, 55905
- Mayo Clinic Cancer Center
-
Saint Cloud, Minnesota, Estados Unidos, 56303
- Coborn Cancer Center
-
Saint Louis Park, Minnesota, Estados Unidos, 55416
- CCOP - Metro-Minnesota
-
Sartell, Minnesota, Estados Unidos, 56377
- Adult and Pediatric Urology, P.L.L.P.
-
Shakopee, Minnesota, Estados Unidos, 55379
- Saint Francis Cancer Center
-
St Paul, Minnesota, Estados Unidos, 55102
- St. Joseph's Hospital
-
St. Cloud, Minnesota, Estados Unidos, 56303
- CentraCare Clinic - River Campus
-
St. Louis Park, Minnesota, Estados Unidos, 55416
- Park Nicollet Health Services
-
St. Paul, Minnesota, Estados Unidos, 55102
- United Hospital
-
St. Paul, Minnesota, Estados Unidos, 55101
- Regions Hospital Cancer Care Center
-
Waconia, Minnesota, Estados Unidos, 55387
- Ridgeview Medical Center
-
Woodbury, Minnesota, Estados Unidos, 55125
- Woodwinds Health Campus
-
-
Montana
-
Billings, Montana, Estados Unidos, 59101
- CCOP - Montana Cancer Consortium
-
Billings, Montana, Estados Unidos, 59101
- Hematology-Oncology Centers of the Northern Rockies - Billings
-
Billings, Montana, Estados Unidos, 59101
- Northern Rockies Radiation Oncology Center
-
Billings, Montana, Estados Unidos, 59101
- St. Vincent Healthcare
-
Billings, Montana, Estados Unidos, 59107-7000
- Deaconess Billings Clinic - Downtown
-
Billings, Montana, Estados Unidos, 59107-5100
- Deaconess Billings Clinic Cancer Center
-
Bozeman, Montana, Estados Unidos, 59715
- Bozeman Deaconess Hospital
-
Butte, Montana, Estados Unidos, 59701
- St. James Community Hospital
-
Helena, Montana, Estados Unidos, 59601
- St. Peter's Hospital
-
Kalispell, Montana, Estados Unidos, 59901
- Kalispell Regional Medical Center
-
Kalispell, Montana, Estados Unidos, 59901
- Glacier Oncology, PLLC
-
Kalispell, Montana, Estados Unidos, 59901
- Kalispell Medical Oncology
-
Missoula, Montana, Estados Unidos, 59801
- Community Medical Center
-
Missoula, Montana, Estados Unidos, 59807-7877
- Montana Cancer Specialists at Montana Cancer Center
-
Missoula, Montana, Estados Unidos, 59807
- Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
-
-
Nebraska
-
Lincoln, Nebraska, Estados Unidos, 68510
- Cancer Resource Center - Lincoln
-
Lincoln, Nebraska, Estados Unidos, 68510
- St. Elizabeth Regional Medical Center
-
Lincoln, Nebraska, Estados Unidos, 68502
- Bryan LGH Medical Center - West
-
-
North Carolina
-
Rutherfordton, North Carolina, Estados Unidos, 28139
- Rutherford Hospital
-
-
North Dakota
-
Bismarck, North Dakota, Estados Unidos, 58501
- Bismarck Cancer Center
-
Bismarck, North Dakota, Estados Unidos, 58501
- Cancer Care Center at Medcenter One Hospital
-
Bismarck, North Dakota, Estados Unidos, 58501
- Mid Dakota Clinic, P. C.
-
Bismarck, North Dakota, Estados Unidos, 58502
- St. Alexius Medical Center
-
Fargo, North Dakota, Estados Unidos, 58122
- CCOP - MeritCare Hospital
-
Fargo, North Dakota, Estados Unidos, 58122
- MeritCare Medical Group
-
Grand Forks, North Dakota, Estados Unidos, 58201
- Altru Cancer Center at Altru Hospital
-
-
Ohio
-
Bowling Green, Ohio, Estados Unidos, 43402
- Wood County Oncology Center
-
Findlay, Ohio, Estados Unidos, 45840
- Blanchard Valley Medical Associates
-
Fremont, Ohio, Estados Unidos, 43420
- Fremont Memorial Hospital
-
Kenton, Ohio, Estados Unidos, 43326
- Kenton Oncology, Incorporated
-
Lima, Ohio, Estados Unidos, 45804
- Lima Memorial Hospital
-
Maumee, Ohio, Estados Unidos, 43537
- Northwest Ohio Oncology Center
-
Maumee, Ohio, Estados Unidos, 43537
- St. Luke's Hospital
-
Oregon, Ohio, Estados Unidos, 43616
- St. Charles Mercy Hospital
-
Oregon, Ohio, Estados Unidos, 43616
- Toledo Clinic - Oregon
-
Sandusky, Ohio, Estados Unidos, 44870
- Firelands Regional Medical Center
-
Sandusky, Ohio, Estados Unidos, 44870
- North Coast Cancer Care, Incorporated
-
Sylvania, Ohio, Estados Unidos, 43560
- Promedica Cancer Center at Flower Hospital
-
Tiffin, Ohio, Estados Unidos, 44883
- Mercy Hospital of Tiffin
-
Toledo, Ohio, Estados Unidos, 43608
- St. Vincent Mercy Medical Center
-
Toledo, Ohio, Estados Unidos, 43606
- Toledo Hospital
-
Toledo, Ohio, Estados Unidos, 43614
- Medical University of Ohio Cancer Center
-
Toledo, Ohio, Estados Unidos, 43623
- Toledo Clinic, Incorporated - Main Clinic
-
Toledo, Ohio, Estados Unidos, 43623
- CCOP - Toledo Community Hospital
-
Toledo, Ohio, Estados Unidos, 43623
- Toledo Surgical Specialists
-
Wauseon, Ohio, Estados Unidos, 43567
- Fulton County Health Center
-
-
Pennsylvania
-
Allentown, Pennsylvania, Estados Unidos, 18105
- Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
-
Danville, Pennsylvania, Estados Unidos, 17822-0001
- Geisinger Medical Center
-
Pittsburgh, Pennsylvania, Estados Unidos, 15212
- Allegheny Cancer Center at Allegheny General Hospital
-
State College, Pennsylvania, Estados Unidos, 16801
- Geisinger Medical Group - Scenery Park
-
Wilkes-Barre, Pennsylvania, Estados Unidos, 18711
- Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
-
-
South Carolina
-
Anderson, South Carolina, Estados Unidos, 29621
- AnMed Health Cancer Center
-
Spartanburg, South Carolina, Estados Unidos, 29303
- CCOP - Upstate Carolina
-
Spartanburg, South Carolina, Estados Unidos, 29303
- Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
-
-
South Dakota
-
Rapid City, South Dakota, Estados Unidos, 57701
- Rapid City Regional Hospital
-
Sioux Falls, South Dakota, Estados Unidos, 57105
- Avera Cancer Institute
-
Sioux Falls, South Dakota, Estados Unidos, 57117-5039
- Sioux Valley Hospital and University of South Dakota Medical Center
-
Sioux Falls, South Dakota, Estados Unidos, 57105
- Medical X-Ray Center, PC
-
-
Wisconsin
-
Green Bay, Wisconsin, Estados Unidos, 54307-3508
- St. Vincent Hospital Regional Cancer Center
-
Green Bay, Wisconsin, Estados Unidos, 54303
- Green Bay Oncology, Limited at St. Mary's Hospital
-
Green Bay, Wisconsin, Estados Unidos, 54303
- St. Mary's Hospital Medical Center - Green Bay
-
Green Bay, Wisconsin, Estados Unidos, 54301-3526
- Green Bay Oncology, Limited at St. Vincent Hospital
-
La Crosse, Wisconsin, Estados Unidos, 54601
- Franciscan Skemp Healthcare
-
Marinette, Wisconsin, Estados Unidos, 54143
- Bay Area Cancer Care Center at Bay Area Medical Center
-
Oconto Falls, Wisconsin, Estados Unidos, 54154
- Green Bay Oncology, Limited - Oconto Falls
-
Sturgeon Bay, Wisconsin, Estados Unidos, 54235
- Green Bay Oncology, Limited - Sturgeon Bay
-
-
Wyoming
-
Sheridan, Wyoming, Estados Unidos, 82801
- Welch Cancer Center at Sheridan Memorial Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
DISEASE CHARACTERISTICS:
Histologically or cytologically confirmed ductal cell or undifferentiated adenocarcinoma of the pancreas
- Previously untreated metastatic disease
- No islet cell or acinar cell carcinoma or cystadenocarcinoma
- No invasion of adjacent organs (i.e., duodenum or stomach) or major blood vessels ( i.e., superior mesenteric artery or celiac artery)
- No CNS metastasis
PATIENT CHARACTERISTICS:
Age
- 18 and over
Performance status
- ECOG 0-2
Life expectancy
- At least 6 months
Hematopoietic
- Absolute neutrophil count ≥ 1,500/mm^3
- Platelet count ≥ 100,000/mm^3
- Hemoglobin ≥ 10.0 g/dL
- No bleeding diathesis or uncontrolled coagulopathy
- No bleeding events within the past 6 months
Hepatic
- Bilirubin ≤ 2 times upper limit of normal (ULN) (stenting allowed)
- AST ≤ 5 times ULN
- No esophageal varices
Renal
- Creatinine ≤ 2 times ULN
- Proteinuria < 1+ by dipstick or urinalysis OR
- Protein < 1 g/24-hr urine collection
- No nephrotic syndrome
Cardiovascular
- No New York Heart Association class II-IV congestive heart failure
- No symptomatic, unstable angina, or coronary artery disease
- No uncontrolled cardiac arrhythmias
- No myocardial infarction within the past 6 months
- No uncontrolled hypertension
- No history of cerebrovascular events
- No clinically significant peripheral arterial disease
- No other clinically significant cardiac disease
Pulmonary
- No hemoptysis within the past 6 months
Immunologic
- No history of allergy or hypersensitivity to bevacizumab, oxaliplatin, or gemcitabine
- No hypersensitivity to Chinese hamster ovary cell products or other recombinant human antibodies
- No known allergy to other platinum compounds
- No ongoing or active infection
Other
- Not pregnant or nursing
- Negative pregnancy test
- Fertile patients must use effective contraception during and for 6 months after completion of study treatment
- No serious, non-healing wound, ulcer, or bone fracture
- No pre-existing peripheral neuropathy > grade 1
- No other malignancy within the past 5 years except basal cell or squamous cell skin cancer, carcinoma in situ of the cervix, or prostate cancer with a Gleason score < 7
- No psychiatric illness or social situation that would preclude study compliance
- No other uncontrolled illness
- No gastrointestinal bleeding within the past 6 months
- No unresolved physical trauma within the past 4 weeks
PRIOR CONCURRENT THERAPY:
Biologic therapy
- More than 4 months since prior immunotherapy or biologic therapy
- No prior adjuvant bevacizumab
- No concurrent immunotherapy
- No concurrent colony-stimulating factors during the first course of study therapy
Chemotherapy
- Recovered from prior chemotherapy
- More than 4 months since prior adjuvant chemotherapy for completely resected disease
- At least 4 months since prior chemoradiotherapy for locally advanced disease
- More than 4 months since prior gemcitabine as a radiosensitizer or as maintenance therapy
- No prior cytotoxic chemotherapy for metastatic disease
- No prior adjuvant oxaliplatin
- No other concurrent chemotherapy
Endocrine therapy
- Not specified
Radiotherapy
- See Chemotherapy
- More than 4 months since prior radiotherapy
- No prior radiotherapy to > 25% of bone marrow
- No prior radiotherapy to sole site of measurable disease unless there is radiologically confirmed progression of the irradiated tumor
- No concurrent radiotherapy
Surgery
- More than 4 weeks since prior major surgery or trauma and recovered
- No concurrent surgery
Other
More than 2 weeks since prior and no concurrent thrombolytic agents
Anticoagulation therapy with warfarin or low molecular weight heparin is allowed provided the following criteria are met:
- At least 2 weeks at a stable dose
- INR 2-3
- No active bleeding or pathologic condition that confers a high risk of bleeding (e.g., tumor involving major vessels or known varices)
- No recent or concurrent participation in another study of experimental drugs
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: gemcitabine + bevacizumab + oxaliplatin
Patients receive gemcitabine IV over 100 minutes and bevacizumab IV over 30-90 minutes on days 1 and 15. Patients also receive oxaliplatin IV over 120 minutes on days 2 and 16. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients achieving a complete response (CR) receive 2 courses of therapy beyond CR. After completion of study treatment, patients are followed every 3-6 months for up to 5 years. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
---|---|
Survival at 6 months
Periodo de tiempo: at 6 months
|
at 6 months
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
---|---|
Supervivencia libre de progresión
Periodo de tiempo: Hasta 5 años
|
Hasta 5 años
|
Sobrevivencia promedio
Periodo de tiempo: Hasta 5 años
|
Hasta 5 años
|
Tiempo hasta el fracaso del tratamiento
Periodo de tiempo: Hasta 5 años
|
Hasta 5 años
|
Objective response rate as measured by RECIST criteria
Periodo de tiempo: Up to 5 years
|
Up to 5 years
|
Median survival
Periodo de tiempo: Up to 5 years
|
Up to 5 years
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Silla de estudio: George P. Kim, MD, Mayo Clinic
Publicaciones y enlaces útiles
Publicaciones Generales
- Kim GP, Alberts SR, Oberg AL, et al.: Phase II trial of bevacizumab, gemcitabine, and oxaliplatin in patients with metastatic pancreatic adenocarcinoma. [Abstract] American Society of Clinical Oncology 2007 Gastrointestinal Cancers Symposium, 19 -21 January 2007, Orlando, Florida A-169, 2007.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Enfermedades del Sistema Digestivo
- Neoplasias
- Neoplasias por sitio
- Enfermedades del sistema endocrino
- Neoplasias del Sistema Digestivo
- Neoplasias de glándulas endocrinas
- Enfermedades pancreáticas
- Neoplasias pancreáticas
- Efectos fisiológicos de las drogas
- Mecanismos moleculares de acción farmacológica
- Agentes antiinfecciosos
- Agentes Antivirales
- Inhibidores de enzimas
- Antimetabolitos, Antineoplásicos
- Antimetabolitos
- Agentes antineoplásicos
- Agentes inmunosupresores
- Factores inmunológicos
- Agentes antineoplásicos inmunológicos
- Inhibidores de la angiogénesis
- Agentes moduladores de la angiogénesis
- Sustancias de crecimiento
- Inhibidores del crecimiento
- Gemcitabina
- Oxaliplatino
- Bevacizumab
Otros números de identificación del estudio
- NCCTG-N034A
- NCI-2012-02655 (Identificador de registro: CTRP (Clinical Trials Reporting System))
- CDR0000430845 (Identificador de registro: PDQ (Physician Data Query))
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Cancer de pancreas
-
Abramson Cancer Center of the University of PennsylvaniaTerminadoPaciente con cancerEstados Unidos
-
Peking Union Medical College HospitalTerminadoEncuesta | Estado nutricional | Paciente con cancerPorcelana
-
Ankara Medipol UniversityReclutamientoCuidados personales | Inmunoterapia | Manejo de síntomas | Paciente con cancerPavo
-
Northwestern UniversityGenzyme, a Sanofi CompanyRetiradoCANCER DE PROSTATAEstados Unidos
-
Fundacao ChampalimaudTerminado
-
University College London HospitalsTerminado
-
GenSpera, Inc.RetiradoCancer de prostata.Estados Unidos
-
University of Colorado, DenverColorado State UniversityRetiradoRealidad virtual | Diagnóstico por imagen | Educación del paciente | Paciente con cancerEstados Unidos
-
Dana-Farber Cancer InstituteTerminadoCancer de RIÑON | Cancer de prostata | Cáncer genitourinarioEstados Unidos
-
Rabin Medical CenterReclutamiento
Ensayos clínicos sobre oxaliplatino
-
SanofiTerminado
-
Universidad de LeónReclutamientoCáncer de colon localmente avanzadoEspaña
-
SanofiTerminadoCáncer gástricoCorea, república de
-
Kangbuk Samsung HospitalTerminadoCáncer de estómagoCorea, república de
-
SanofiTerminadoNeoplasias pancreáticasCanadá
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkActivo, no reclutandoAdenocarcinoma de la unión gastroesofágica en estadio clínico III AJCC v8 | Adenocarcinoma de esófago en estadio clínico IIA AJCC v8 | Adenocarcinoma de esófago en estadio clínico III AJCC v8 | Adenocarcinoma de esófago en estadio clínico IVA AJCC v8 | Adenocarcinoma de esófago en estadio... y otras condicionesEstados Unidos